Diagnostic Performance of Magnetic Resonance Imaging for Assessing Tumor Response in Patients With HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy Is Associated With Molecular Biomarker Profile

Clinical Breast Cancer - United States
doi 10.1016/j.clbc.2012.01.009
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Role of Magnetic Resonance Imaging in Assessing Residual Disease and Pathologic Complete Response in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: A Systematic Review

Insights into Imaging
Nuclear MedicineRadiologyImaging
2013English

Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer

New England Journal of Medicine
Medicine
2012English

Magnetic Resonance Imaging Tumor Regression Shrinkage Patterns After Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer: Correlation With Tumor Biological Subtypes and Pathological Response After Therapy

Tumor Biology
MedicineCancer Research
2017English

Role of Magnetic Resonance Imaging in the Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy

In Vivo
BiochemistryMedicineGeneticsPharmacologyMolecular Biology
2020English

MRP1 but Not MDR1 Is Associated With Response to Neoadjuvant Chemotherapy in Breast Cancer Patients

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2013English

Magnetic Resonance Imaging Features of Breast Cancer According to Intrinsic Subtypes: Correlations With Neoadjuvant Chemotherapy Effects

SpringerPlus
Multidisciplinary
2014English

Complete Pathological Response in Patients With Locally Advanced Cancer of Breast and Positive Her2/Neu With Neoadjuvant Chemotherapy

BMC Cancer
Cancer ResearchOncologyGenetics
2007English

RB-Pathway Disruption Is Associated With Improved Response to Neoadjuvant Chemotherapy in Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2012English

Indoleamine-2,3-Dioxygenase and Interleukin-6 Associated With Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy